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Background: The reclassification of prescription only medicines to pharmacy and general sales list
medicines (also known as non-prescription medicines) provides the public with greater access to medicines
that they can purchase for self-care. There is evidence that non-prescription medicines may be associated
with inappropriate supply. This study investigated factors predicting evidence-based (guideline compliant)
supply or non-supply of non-prescription medicines.
Method: Secondary analysis of results from a randomised controlled trial of educational interventions to
promote the evidence based supply of non-prescription medicines. Ten actors made simulated patient
(customer) visits to 60 community pharmacies using seven scenarios reflecting different types of
presentations. The dependent variable was appropriate (guideline compliant) supply of antifungal
medication for treatment of vaginal candidiasis.
Results: No significant association was shown between guideline compliant behaviour and pharmacy type
or location, or with the actor making the visit. The likelihood of guideline compliant outcome was
significantly greater with symptom presentations than with condition or product presentations (p,0.001).
The likelihood of a guideline compliant outcome increased (a) as more information was exchanged
(p,0.001), (b) with the use of WWHAM (a mnemonic frequently used by medicine counter assistants
during consultations for non-prescription medicines) (p,0.001); (c) when specific WWHAM questions
were used (including ‘‘description of symptoms’’ (p,0.001) and ‘‘whether other medication was currently
being used’’ (p,0.001); and (d) in consultations involving solely pharmacists compared with those
involving only medicine counter assistants (p = 0.017). After adjustment for presentation type, a significant
association persisted between appropriate outcome and consultations with WWHAM scores of 2 and >3,
respectively.
Conclusions: The nature and extent of information exchange between pharmacy staff and customers has a
strong influence on the guideline compliant supply of non-prescription medicines. Future interventions to
promote the safe and effective use of non-prescription medicines should address the apparent deficit in
communication between pharmacy staff in general, and medicine counter assistants in particular, which
may reflect both pharmacy staff skills and customer expectations.
B
urgeoning healthcare costs are of worldwide concern.
Expenditure on medication in particular is increasing at
an unsustainable rate. One strategy adopted by many
governments, including the UK, has been the reclassification
of medicines originally available only on prescription to legal
categories that enable them to be purchased from community
pharmacies (pharmacy-only medicines) and from other retail
outlets (General Sales List items), thus removing them from
national medicine budgets. Reclassification has resulted in
medicines of increasing potency becoming available for
purchase, including antifungal agents for vaginal candidiasis,
H2-receptor antagonists and proton pump inhibitors and,
more recently, statins (in the UK).1
There are concerns regarding the risks associated with the
public’s enhanced access to these medicines, as well as with
the ability of community pharmacy staff to ensure the safe,
effective, and evidence-based supply of reclassified medi-
cines.2–5 The inappropriate supply of non-prescription medi-
cines has many implications including misdiagnosis, delayed
access to correct treatment, and adverse drug reactions.6 It is
therefore important to ensure the appropriate supply of these
medicines.
Between 2000 and 2001 a randomised controlled trial was
conducted in 60 community pharmacies from Grampian,
Scotland to compare the effectiveness and efficiency of two
educational strategies as methods of improving the appro-
priate (guideline compliant) supply of antifungal medicines
for the treatment of vaginal candidiasis.7 The outcome
measure (appropriateness of sale or no sale) was derived
using pre- and post-intervention visits from simulated
patients (actors) who performed scenarios in each of the
participating pharmacies. The training of the actors is
presented fully elsewhere.8 No statistically significant effect
was shown with either intervention, either singly or
combined. Possible barriers to the evidence-based supply of
non-prescription medicines from community pharmacies
were investigated in a qualitative study.9 Suboptimal com-
munication was identified as one of the most important
barriers to this activity.
The purpose of the study presented here was to conduct a
secondary analysis of the data derived from the randomised
controlled trial to identify variables predictive of guideline
compliant supply (or non-supply) of an antifungal for the
treatment of vaginal candidiasis. This was an exploratory
study which aimed to maximise the issues that could be
investigated from an existing data set.
The objective of this study was to determine whether the
following factors were associated with appropriate outcome:
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(1) consultation (scenario) characteristics; (2) pharmacy
characteristics; and (3) customer characteristics.
METHODS
The randomised controlled trial from which these data were
derived is presented in full elsewhere.7 The pharmacies were
stratified by type (independent, small chain, and large chain)
and location (rural, town, urban) and then randomised into
four trial groups (control, educational outreach, continuing
professional development, and educational outreach with
continuing professional development). Nine actors conducted
384 simulated patient visits to 60 community pharmacies.
The data for a tenth actor were excluded from all analyses
because of doubts about its veracity. This decision was made
before any analyses were undertaken. The excluded visits
comprised 9% of the total available data. Seven scenarios
were presented in each pharmacy during the study. Of these,
three represented product requests (for example, ‘‘I would like
a tube of Canesten’’), two were condition presentations (for
example, ‘‘I need something for thrush’’), and two scenarios
represented symptom presentations (for example, ‘‘I have an
itch down below’’). None of the actors gave all seven scenarios.
Immediately after each visit the actor completed a 15-item
data collection form, indicating which questions had been
asked or information elicited by pharmacy staff during the
consultation. Each question that was asked/item of informa-
tion elicited received a score of 1, with a maximum possible
score of 15. This was defined as the ‘‘total information score’’.
Within the pharmacy profession there is an established
framework called WWHAM10 11 which has been promoted as
a decision aid for the supply of non-prescription medicines.
WWHAM stands for Who is it for?; What are the symptoms?;
How long have the symptoms been present?; Any other
medication being used at present?; and What Medication has
been tried already? Four of the 15 items on the actors’ data
collection forms were WWHAM questions. The question
concerning duration of symptoms was not recorded on the
form (due to an oversight). Each question that was asked/
item of information elicited received a score of 1, with a
maximum possible score of 4. This was defined as the
‘‘WWHAM score’’.
Analysis of data
Statistical analyses were performed using SPSS version11.5.
The primary outcome measure was ‘‘appropriate outcome’’—
that is, the outcome complied with evidence-based guidelines
for the treatment of vaginal candidiasis.12 For example, the
guidelines recommended that antifungal medicines should
not be sold to treat pregnant women so, if an antifungal was
sold to the actor during the ‘‘pregnancy’’ scenario, this was
deemed to be a non-compliant (or inappropriate) outcome.
The total information score and WWHAM score were
analysed as continuous variables using non-parametric
methods. x2 tests were performed to assess the association
between two categorical factors. The ‘‘scenario’’ variable was
reduced from seven to three categories representing product,
condition, and symptom consultations. Pharmacies were
categorised by type (single, small chain (n = 2–9), large
chain (n.9)) and location (rural (,4000 inhabitants), town
(4000–9000), urban (.9000)). Logistic regression was
performed to identify independent predictors of appropriate
outcomes only. Variables that showed a statistically signifi-
cant association (i.e. p,0.05) with an appropriate outcome in
the univariate analyses were combined in these analyses.
RESULTS
Consultation characteristics
Significant differences (p,0.001) were shown with guideline
compliance across the seven individual scenarios, as well as
across the three types of presentation (symptom, condition,
and product presentations). Symptom presentation scenarios
were most likely to result in an appropriate outcome. The
total information score and WWHAM score were calculated
for 327 (85.2%) and 351 (91.4%) visits, respectively, due to
missing data with some of their components. Symptom
presentations had higher WWHAM scores and total informa-
tion scores than condition or product presentations
(p,0.001, table 1). A highly significant positive association
(p,0.001) was also shown between the total information
score and appropriate outcome. Condition presentations also
had significantly higher WWHAM scores than product
presentations (p,0.001).
A highly significant positive association was shown
between the WWHAM score and guideline compliance
(appropriate outcome) (p,0.001, table 2). Guideline com-
pliance was also associated with specific questions (table 3).
Achieving an appropriate outcome was 1.4–4.5 times more
likely depending on the specific question that was asked or
information elicited. WWHAM scores varied significantly
across all scenarios (p,0.001). Significant variation
(p,0.001) was also shown across the seven scenarios for
three of the four individual WWHAM questions. No
significant difference was shown with ‘‘treatment tried
already’’ (p.0.05; data not shown).
After adjustment for the WWHAM score, consultations
involving symptom presentations had over twice the chance
of an appropriate outcome (OR 2.15, 95% CI 1.20 to 3.85)
compared with other consultations. After adjusting for
scenario type, consultations with a WWHAM score of 2 (OR
3.23, 95% CI 1.73 to 6.10) or a WWHAM score of 3 or 4 (OR
5.56, 95% CI 2.46 to 12.56) were significantly more likely to
result in an appropriate outcome (data not shown).
When individual WWHAM questions were included in the
logistic model with scenario type, ‘‘description of symptoms’’
(OR 4.45, 95% CI 2.80 to 7.07) and ‘‘taking other medication’’
(OR 3.85, 95% CI 2.26 to 6.58) remained significant
predictors of an appropriate outcome. Furthermore, signifi-
cance persisted with these two WWHAM components when
the logistic model comprised all four WWHAM items and
Table 1 Effect of type of presentation and guideline compliant behaviour on WWHAM
and total information scores
Type of
presentation
Appropriate
outcome, n (%)
Total WWHAM score
Median (IQR)
Total information score
Median (IQR)
Product 47 (28.0) 0.00 [0.00–1.00] 1.00 [0.00–3.00]
Condition 30 (31.3) 1.00 [0.00–2.00] 4.00 [1.00–6.00]
Symptom 69 (57.5) 2.00 [1.00–2.00] 6.00 [4.00–7.00]
p value* ,0.001* ,0.001** ,0.001**
IQR, interquartile range.
*x2 or Kruskal-Wallis tests showing significance of difference in appropriate outcome, total WWHAM score, and
total information score across the three types of presentation.
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scenario type (table 4), although the magnitude of the odds
ratio was reduced.
Pharmacy characteristics
No significant association was shown between pharmacy
type or location in terms of appropriate outcome. Of the 384
visits, 36 (9.4%) were perceived by the actors to involve only a
pharmacist, 140 (36.5%) to involve solely a medicine counter
assistant, and 77 (20.1%) to involve both a pharmacist and a
medicine counter assistant. The member of staff could not be
identified in 131 (34.1%) visits. The analysis of staff member
and appropriateness was limited to 171 visits (pharmacist or
medicine counter assistant only), and 253 visits when visits
involving both a pharmacist and medicine counter assistant
were included.
A highly significant difference (p,0.001) was shown with
WWHAM score and total information score and the member
of pharmacy staff involved in the consultation, with
pharmacists asking significantly more questions or eliciting
more information than medicine counter assistants.
Consultations involving only pharmacists were significantly
more likely to be guideline compliant than those with
medicine counter assistants only (52.8% (n = 19) v 31.4%
(n = 44), p = 0.017), and consultations involving both med-
icine counter assistants and pharmacists were also signifi-
cantly more likely to be guideline compliant than those
involving medicine counter assistants only (61.0% (n = 47) v
31.4% (n = 44), p,0.001).
Pharmacists asked more WWHAM questions (or elicited
information relating to these questions) than medicine
counter assistants (p,0.001). The type of information elicited
by pharmacists and medicine counter assistants varied, with
statistically significant differences being shown for 10 of the
15 questions or types of information elicited (table 5). These
significant associations between staff member and guideline
compliance did not persist after adjusting for the effect of
scenario type and the number of WWHAM questions asked
or information elicited (data not shown).
Customer characteristics
No significant association was shown between the nine
actors and appropriate outcome. However, significant varia-
tion was shown across some (but not all) scenarios,
depending on the actor who presented them. For example,
with scenario 7, three of the four actors’ visits all resulted in
appropriate outcomes while, with the remaining actor (actor
9) only two visits (16.7%) resulted in an appropriate outcome
(data not shown).
DISCUSSION
The likelihood of guideline compliant behaviour was influ-
enced by the way in which customers present in the
pharmacy, which affected the extent of information
exchange between the customer and pharmacy staff.
Guideline compliant behaviour was least likely to occur with
product presentations. It may be easier to engage in
Table 2 Association between WWHAM score and appropriate (guideline compliant)
outcome
WWHAM
score
Appropriate
outcome, n (%) Total (n) Odds ratio 95% CI
0 27 (21.1) 128 – –
1 28 (29.5) 95 1.56 0.85 to 2.88
2 46 (52.3) 88 4.10 2.26 to 7.45
3 21 (61.8) 34 6.95* 3.20 to 15.10
4 5 (83.3) 6
*Categories 3 and 4 combined due to small numbers.
Table 3 Association between information exchange on appropriateness of outcome
Appropriate outcome (n (%))
Odds
ratio 95% CI
Information
not elicited
Information
elicited
Whether pregnant 127 (37.1) 19 (45.2) 1.40 0.73 to 2.67
Whether any treatment tried
currently
133 (37.2) 12 (48.0) 1.56 0.69 to 3.52
Whether GP had diagnosed
thrush previously
105 (34.7) 39 (50.0) 1.89 1.14 to 3.12
Frequency of thrush in previous
6 months
102 (33.9) 42 (52.5) 2.16 1.31 to 3.55
Which previous treatment
for thrush
92 (33.1) 54 (51.9) 2.18 1.38 to 3.45
Treatment of sexual partner 142 (37.7) 4 (57.1) 2.21 0.49 to 10.00
Who treatment for 35 (25.5) 95 (43.4) 2.23 1.40 to 3.56
Whether had thrush before 52 (27.8) 90 (48.9) 2.49 1.62 to 3.83
Whether vaginal odour a
symptom
129 (36.0) 15 (62.5) 2.96 1.26 to 6.95
Whether itch was a
symptom
58 (26.7) 69 (52.7) 3.05 1.93 to 4.81
Whether taking other
medication
99 (31.9) 47 (64.4) 3.85 2.26 to 6.58
Recommendation to consult GP 70 (27.1) 74 (59.7) 3.99 2.53 to 6.25
Whether vaginal discharge
a symptom
94 (30.8) 51 (65.4) 4.24 2.51 to 7.18
Description of symptoms 71 (26.9) 72 (62.1) 4.45 2.80 to 7.07
Preparation sold for sexual
partner
142 (37.5) 3 (75.0) 5.00 0.52 to 48.60
}
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information exchange (communication) with customers
making non-product requests (that is, advice) as pharmacy
staff can discuss different treatment options in response to a
clear request for advice. Product requests may be perceived as
having fewer opportunities to enter into discussion with
customers, as well as being more intimidating and difficult.13
Customer resistance to questioning and perceived limited
ability of medicine counter assistants in information gather-
ing and advice provision have been reported previously.13 14
Variation has also been shown with patient counselling by
pharmacists for patients receiving prescribed medications,
with the extent of information exchange varying depending
on whether the prescription is acute (that is, a newly
prescribed medicine) or a refill (that is, chronic or repeat
medication).15 Deficiencies with information gathering by
community pharmacists and simulated patients consulta-
tions have been shown,16–18 as well as problems with tailoring
advice to customers and patients in pharmacy settings.19 20
Pressure to maintain good relationships with customers
may influence pharmacy staff decisions to supply non-
prescription medicines, as has been shown with general
practitioners and their decision to prescribe for their
patients.21 Perceived patient demand has also been shown
to influence the extent to which general practitioners intend
to comply with prescribing guidelines.22 The previous use of a
prescribed medicine may also encourage patients to demand
or expect similar treatment in the future (regardless of its
clinical appropriateness),23 and this may also occur with the
supply of non-prescription medicines from community
pharmacies.
Healthcare professionals and communication skil ls
Patient satisfaction has been shown to be influenced by
doctor-patient communication,24 and it is likely that customer
satisfaction will also be affected by the communication skills
of pharmacy staff. However, it is not only the number of
questions that are asked nor items of information elicited
that are important in achieving guideline compliant beha-
viour, but the specific information that is elicited. In this
study the ‘‘description of symptoms’’ was the WWHAM item
most strongly associated with an appropriate outcome. In
addition, establishing whether the customer was using other
medication concurrently was also strongly associated with an
appropriate outcome. In this study, pharmacists were also
more likely to elicit this information than medicine counter
assistants. Furthermore, customers who report using con-
current medication may be more likely to be referred to the
pharmacist, and this in turn may increase the chance of
achieving an appropriate outcome. A review of communica-
tion between patients and healthcare professionals in relation
to medicines showed that interventions which encourage
patients to ask questions about their treatment may be
partially effective.25 A review of communication skills
training for health professionals (which did not include
pharmacists or their staff) showed that training increased the
process and content of consultations with anxious and
depressed patients, but did not enhance patient satisfaction
or patient outcomes.26
Consultations that solely involved pharmacists were
significantly more likely to be guideline compliant than
those involving only medicine counter assistants. This is
Table 4 Association between scenario type, individual WWHAM item, and appropriate outcome
WWHAM item
Product
n (%)
Condition
n (%)
Symptom
n (%) p value OR* 95% CI ORadj 95% CI
Who for 75 (44.6) 70 (74.5) 74 (78.7) ,0.001 2.23 1.40 to 3.56 0.95 0.52 to 1.73
Description of symptoms 28 (16.8) 21 (21.9) 67 (57.3) ,0.001 4.45 2.80 to 7.07 2.94 1.60 to 5.42
Other medication taken 19 (11.3) 19 (20.0) 35 (29.2) 0.001 3.85 2.26 to 6.58 3.39 1.77 to 6.48
Treatment tried already 5 (3.0) 7 (7.3) 13 (10.9) 0.026 1.56 0.69 to 3.52 0.72 0.25 to 2.04
*Logistic model includes each individual WWHAM question and scenario type.
Logistic model includes all four WWHAM questions and scenario type.
Table 5 Relationship between information exchange and member of staff (pharmacist or
medicine counter assistant) (n = 171* visits)
Pharmacist
n (%)
Medicine counter
assistant
n (%) Odds ratio 95% CI
Treatment of sexual partner 0 5 (3.6) – –
Preparation sold for sexual partner 0 (0) 1 (0.7) – –
Whether GP had diagnosed thrush
previously
6 (16.7) 17 (12.2) 1.44 0.52 to 3.95
Whether pregnant 5 (13.9) 14 (10.0) 1.45 0.49 to 4.34
Frequency of thrush in previous
6 months
8 (22.9) 21 (15.1) 1.67 0.67 to 4.16
Which previous treatment for thrush 13 (36.1) 24 (17.1) 2.73 1.22 to 6.14
Whether itch a symptom 19 (54.3) 34 (25.8) 3.42 1.58 to 7.40
Whether had thrush before 23 (63.9) 42 (30.4) 4.04 1.87 to 8.74
Whether vaginal discharge a symptom 13 (36.1) 16 (11.5) 4.35 1.85 to 10.23
Whether vaginal odour a symptom 5 (13.9) 4 (2.9) 5.44 1.38 to 21.46
Recommendation to consult GP 22 (61.1) 22 (15.7) 8.43 3.75 to 18.95
WWHAM questions
‘‘Whether taking other medication?’’ 9 (25.0) 16 (11.5) 2.56 1.03 to 6.41
‘‘Who treatment for?’’ 25 (73.5) 59 (43.1) 3.67 1.60 to 8.45
‘‘Any treatment tried currently?’’ 6 (16.7) 5 (3.6) 5.40 1.55 to 18.87
‘‘Description of symptoms?’’ 18 (51.4) 20 (14.4) 6.30 2.79 to 14.23
*Missing data (n = 5).
25 (73.5%) of the 34 visits where a pharmacist was solely involved were associated with an appropriate outcome
and 59 (43.1%) of the 137 visits where a medicine counter assistant was solely involved were associated with an
appropriate outcome.
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unsurprising, considering that pharmacists are highly trained
professionals and their activities are regulated by the Royal
Pharmaceutical Society of Great Britain. In the UK medicine
counter assistants must have successfully completed an
accredited medicine counter assistant qualification within
3 years of commencing their employment,27 but they are
currently unregulated and unregistered. As such, there is no
single organisation responsible for the provision of ongoing
training to these individuals. The pharmacist in charge of a
pharmacy is responsible for ensuring that the staff are
appropriately trained and that their ongoing training needs
are identified and addressed.28 29
Limitations of the study
The data recorded by the actors on the data collection forms
were not validated. One method that could be adopted in
future studies of this type to overcome this limitation would
be the inclusion of covert audiotaping of the consultations
(with ethical approval).
This study referred only to the supply of antifungal
medicines for the treatment of vaginal candidiasis, so the
results may not be generalisable to all non-prescription
medicines. Indeed, this condition and requests for products
for its treatment may represent one end of the spectrum of
non-prescription medicine consultations because this is an
intimate infection and therefore a potentially sensitive topic.
Pharmacy staff may feel less able to access the type of
information that they would normally explore when inform-
ing their decision to supply a non-prescription medicine.
However, this is the first study of its type to explore
measurable factors and their effect on the appropriate supply
of antifungal agents, and the findings could be considered in
relation to the supply of all non-prescription medicine in
general.
The type of staff member could not be identified in 131
(34%) visits; therefore, when analyses were limited to visits
where the staff member was identifiable the statistical power
was reduced.
Implications of findings for health systems
The reclassification of medicines is an ongoing process, so
mechanisms are needed to enhance their appropriate supply.
This study shows the importance of information gathering to
inform the decision to supply non-prescription medicines. As
such, strategies to enhance information gathering may result
in the more appropriate supply of these medicines.
Interventions that encourage customers to present symptoms
or which improve information provided by pharmacists and
medicine counter assistants might also be effective.
Future research
If, as these results suggest, the main influence on the
appropriate supply of non-prescription medicines is the
nature and extent of information exchange between phar-
macy staff and customers, then future interventions should
address the apparent deficit in communication skills of
pharmacy staff in general, and medicine counter assistants in
particular. Future initiatives could also explore strategies to
enhance the public’s awareness and understanding of the
need for pharmacy staff to have information about them
when buying a non-prescription medicine. These results are
being used to inform ongoing research into promoting the
evidence-based supply of non-prescription medicines from
community pharmacies.
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